Burkitt Lymphoma Genetic Testing, FISH, Tissue
- Diagnosis of Burkitt lymphoma
- Management of Burkitt lymphoma (therapy treatment and disease management)
- Rule out Burkitt lymphoma from other similar symptomatic lymphomas and leukemis
At least 200 interphase cells will be counted for each sample. Dual fusion pattern at or greater than 3% is considered positive for t(8;14)(q24;q32). Break-apart pattern at or greater than 5% is considered positive for an (8q24) rearrangement.
Increased in (detected):
- Endemic Burkitt lymphoma
- Sporadic Burkitt lymphoma
- Immunodeficiency-associated Burkitt lymphoma
The critical point in the diagnosis of BL is the distinction between BL and diffuse large B cell lymphoma (DLBCL), the most common form of non-Hodgkin’s lymphoma in adults, as the treatment of these two diseases differs.
Negative for translocations
Less than 3% dual fusion pattern for t(8;14)(q24;q32), and less than 5% break-apart pattern for an (8q 24) rearrangement.
Fluorescent In Situ Hybridization (FISH), Real-time PCR using specific probes for translocations, PCR with chip array technology, Flow Cytometry Gene expression profiling microarrays have shown promising results in this field.
Paraffin-embedded, formalin-fixed tissue block.
Specimen Stability
Paraffin-embedded formalin fixed tissue:
- Ambient: indefinitely
- Burkitt D. Br Jour Sur. 1958; 46 (197): 218–23. [PMID: 13628987]
- Curr Opin Hematol. 2007; 14 (4): 375–81. [PMID: 17534164]
- Arch Pathol Lab Med. 2004; 128 (5): 549–52. [PMID: 1508627]